YTHDC2 and hepatocellular carcinoma: A study found that YTHDC2 expression levels were upregulated in HCC tissues while FTO expression levels were decreased, and functional single nucleotide polymorphisms (SNPs) in YTHDC2 and FTO were found to have prognostic value in TACE-treated HCC patients (Liu et al., 2021c).